• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC NEUROMODULATION VERCISE GEVIA; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC NEUROMODULATION VERCISE GEVIA; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS Back to Search Results
Model Number DB-1200-S
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Depression (2361); Shaking/Tremors (2515)
Event Date 10/28/2020
Event Type  Injury  
Event Description
It was reported by the deep brain stimulation (dbs) patient that two days after the implant procedure the tremor returned and was worse.The patient explained that the when the stimulation was turned on the tremor was better than when the stimulation was turned off.The patient could no longer feed herself, go to the bathroom independently, she was living in an assisted living home and was depressed.The physician attempted reprogramming twice a week for a year but the issue remained.The physician did not believe the device or procedure contributed to the worsening of the tremor but rather it was a result of the progression of the patient's condition.The physician revised the patient even though there was a small chance of improvement.After the revision procedure, the left replacement lead was confirmed by computed tomography (ct) to be off target so the patient was brought back to the operating room (or), later that evening, and a new lead was placed in the target location.The patient was doing well post-operatively.
 
Manufacturer Narrative
Additional suspect medical device components involved in the event: product family: dbs-linear leads.Upn: m365db2202450.Model: db-2202-45.Serial: (b)(4).Batch: 7076450.Product family: dbs-linear leads.Upn: m365db2202450.Model: db-2202-45.Serial: (b)(4).Batch: 7076603.Product family: dbs-linear leads.Upn: m365db2202450.Model: db-2202-45.Serial: (b)(4).Batch: 7093916.
 
Event Description
It was reported by the deep brain stimulation (dbs) patient that two days after the implant procedure the tremor returned and was worse.The patient explained that the when the stimulation was turned on the tremor was better than when the stimulation was turned off.The patient could no longer feed herself, go to the bathroom independently, she was living in an assisted living home and was depressed.The physician attempted reprogramming twice a week for a year but the issue remained.The physician did not believe the device or procedure contributed to the worsening of the tremor but rather it was a result of the progression of the patient's condition.The physician revised the patient even though there was a small chance of improvement.After the revision procedure, the left replacement lead was confirmed by computed tomography (ct) to be off target so the patient was brought back to the operating room (or), later that evening, and a new lead was placed in the target location.The patient was doing well post-operatively.The explanted leads were discarded by the facility.
 
Manufacturer Narrative
Additional suspect medical device components involved in the event: product family: dbs-linear leads.Upn: m365db2202450.Model: db-2202-45.Serial: (b)(6).Batch: 7076450.Product family: dbs-linear leads upn: m365db2202450.Model: db-2202-45.Serial: (b)(6).Batch: 7076603.Product family: dbs-linear leads.Upn: m365db2202450.Model: db-2202-45.Serial: (b)(6).Batch: 7093916.Correction to the initial mdr in field b5.The explanted leads were not returned as they were discarded by the facility.Analysis of the returned ipg indicated that the ipg passed all tests performed.However, the device exhibited an electrocautery burn mark on the front face of the case.The damage resulted from the explant procedure and is not considered a failure.A product labeling review identified that the device was used per the instructions for use (ifu) product label.Additionally, the ifu states that worsening of disease symptoms, potentially caused by loss of stimulation, medication changes, surgery or illness are known risks with the use of dbs.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VERCISE GEVIA
Type of Device
STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS
Manufacturer (Section D)
BOSTON SCIENTIFIC NEUROMODULATION
25155 rye canyon loop
valencia CA 91355
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
cashel road
clonmel
EI  
Manufacturer Contact
erik sherburne
25155 rye canyon loop
valencia, CA 91355
7632920920
MDR Report Key15392221
MDR Text Key299580687
Report Number3006630150-2022-04649
Device Sequence Number1
Product Code NHL
UDI-Device Identifier08714729984443
UDI-Public08714729984443
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer,Health Professional,Company Representative
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 11/07/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date09/15/2022
Device Model NumberDB-1200-S
Device Catalogue NumberDB-1200-S
Device Lot Number744209
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 08/12/2022
Initial Date FDA Received09/09/2022
Supplement Dates Manufacturer Received10/14/2022
Supplement Dates FDA Received11/07/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured09/15/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age81 YR
Patient SexFemale
-
-